Scalpel Versus Diathermy for Transverse Abdominal Incision in First Elective Caesarean Section
Launched by AZIENDA OSPEDALIERO-UNIVERSITARIA CONSORZIALE POLICLINICO DI BARI · Jun 7, 2023
Trial Information
Current as of May 30, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to compare two different methods for making skin incisions during a first elective cesarean section (CS), specifically using a scalpel versus diathermy, which is a technique that uses heat to cut tissue. The researchers want to find out if one method causes less blood loss, takes less time, results in less pain after surgery, and leads to better healing and cosmetic results.
To be eligible for the study, women must be at least 18 years old, have a body mass index (BMI) within a certain range, and be having their first cesarean delivery for specific reasons, like a breech baby or failed labor induction. Participants will need to provide informed consent and will not have a history of previous abdominal surgeries. The study is not yet recruiting participants, so there's no immediate action needed. If you or someone you know is considering participating, it’s a chance to contribute to important research that could improve cesarean surgery outcomes for future mothers.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Women without a history of previous cesarean section or other abdominal surgery
- • 2. Age greater then 18 years (only adult patients)
- • 3. Body Mass Index (BMI) between 18.5 and 29.9 kg/m2
- • 4. Gestational age greater then 37 weeks (at term pregnancies)
- • 5. No contraindications to spinal anesthesia
- • 6. Indication to elective CS: extra-obstetrical reasons, failure of medical induction of labor, breech fetal presentation
- • 7. Informed consent
- Exclusion Criteria:
- • 1. Women refusing to participate in the study
- • 2. Women undergoing urgency or emergency cesarean deliveries
- • 3. Women with a history of previous cesarean section or abdominal surgery
- • 4. Women with multifetal pregnancies
- • 5. Necessity of general anesthesia
- • 6. Use of anticoagulants
- • 7. Patients needing a median longitudinal abdominal section
- • 8. Patients with pacemakers
- • 9. Allergy to cephalosporins
- • 10. Any medical disorder that can affect wound healing as diabetes, hypertension, hepatic or renal diseases, chronic anemia, chronic skin conditions, congenital or acquired bleeding diathesis.
About Azienda Ospedaliero Universitaria Consorziale Policlinico Di Bari
The Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari is a prominent healthcare institution in Italy, dedicated to advancing medical research and clinical excellence. As a leading clinical trial sponsor, it integrates hospital and university resources to foster innovative research initiatives aimed at improving patient care and treatment outcomes. The institution is committed to upholding the highest ethical standards in clinical trials, ensuring rigorous scientific methodologies and patient safety. With a multidisciplinary approach, the Policlinico di Bari collaborates with various academic and research organizations, positioning itself at the forefront of medical discovery and healthcare advancement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bari, , Italy
Patients applied
Trial Officials
Amerigo Vitagliano, MD, PhD
Principal Investigator
"Aldo Moro" University of Bari
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported